Home » Topics » Regulatory

Regulatory
RSS

Topline results from pivotal Metformin GR study

Dec. 16, 2003

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Dec. 11, 2003

Risperdal approved for bipolar mania

Dec. 10, 2003

Cipralex approved in select European countries for social anxiety disorder

Dec. 9, 2003

U.S. launch of Risperdal Consta

Dec. 9, 2003

Zorbtive receives FDA approval for short bowel syndrome

Dec. 5, 2003

Sepracor reports phase III program results for Xopenex HFA MDI

Dec. 4, 2003

German approval for Leuprogel one-month depot product

Dec. 4, 2003

Gadovist 1.0 receives E.U. approval for MRA

Dec. 2, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...